NVCR logo

NovoCure Limited (NVCR) Cash From Operations

Annual CFO:

-$26.37M+$46.97M(+64.04%)
December 31, 2024

Summary

  • As of today, NVCR annual cash from operations is -$26.37 million, with the most recent change of +$46.97 million (+64.04%) on December 31, 2024.
  • During the last 3 years, NVCR annual cash from operations has fallen by -$109.13 million (-131.86%).
  • NVCR annual cash from operations is now -126.60% below its all-time high of $99.15 million, reached on December 31, 2020.

Performance

NVCR Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRcash flow metrics

Quarterly CFO:

$20.57M+$36.51M(+229.10%)
September 30, 2025

Summary

  • As of today, NVCR quarterly cash from operations is $20.57 million, with the most recent change of +$36.51 million (+229.10%) on September 30, 2025.
  • Over the past year, NVCR quarterly cash from operations has increased by +$10.20 million (+98.28%).
  • NVCR quarterly cash from operations is now -61.53% below its all-time high of $53.48 million, reached on December 31, 2020.

Performance

NVCR Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRcash flow metrics

TTM CFO:

-$34.48M+$10.20M(+22.83%)
September 30, 2025

Summary

  • As of today, NVCR TTM cash from operations is -$34.48 million, with the most recent change of +$10.20 million (+22.83%) on September 30, 2025.
  • Over the past year, NVCR TTM cash from operations has increased by +$3.00 million (+8.00%).
  • NVCR TTM cash from operations is now -126.85% below its all-time high of $128.40 million, reached on June 30, 2021.

Performance

NVCR TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

NVCR Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+64.0%+98.3%+8.0%
3Y3 Years-131.9%-8.2%-170.5%
5Y5 Years-199.1%-33.6%-165.5%

NVCR Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-131.9%+64.0%-8.2%+157.7%-170.5%+60.9%
5Y5-Year-126.6%+64.0%-61.5%+157.7%-126.8%+60.9%
All-TimeAll-Time-126.6%+75.5%-61.5%+157.7%-126.8%+71.3%

NVCR Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
$20.57M(+229.1%)
-$34.48M(+22.8%)
Jun 2025
-
-$15.94M(+55.3%)
-$44.68M(-46.7%)
Mar 2025
-
-$35.66M(-933.5%)
-$30.46M(-15.5%)
Dec 2024
-$26.37M(+64.0%)
-$3.45M(-133.3%)
-$26.37M(+29.6%)
Sep 2024
-
$10.38M(+703.3%)
-$37.48M(+44.2%)
Jun 2024
-
-$1.72M(+94.6%)
-$67.17M(+23.8%)
Mar 2024
-
-$31.57M(-116.9%)
-$88.18M(-20.2%)
Dec 2023
-$73.34M(-338.2%)
-$14.56M(+24.6%)
-$73.34M(-17.4%)
Sep 2023
-
-$19.31M(+15.1%)
-$62.48M(-201.1%)
Jun 2023
-
-$22.74M(-35.9%)
-$20.75M(-216.9%)
Mar 2023
-
-$16.73M(-351.2%)
$17.75M(-42.4%)
Dec 2022
$30.79M(-62.8%)
-$3.71M(-116.5%)
$30.79M(-37.0%)
Sep 2022
-
$22.42M(+42.2%)
$48.90M(-3.9%)
Jun 2022
-
$15.76M(+527.5%)
$50.88M(-17.0%)
Mar 2022
-
-$3.69M(-125.6%)
$61.29M(-25.9%)
Dec 2021
$82.76M(-16.5%)
$14.40M(-41.0%)
$82.76M(-32.1%)
Sep 2021
-
$24.40M(-6.8%)
$121.83M(-5.1%)
Jun 2021
-
$26.17M(+47.2%)
$128.40M(+11.7%)
Mar 2021
-
$17.78M(-66.8%)
$114.97M(+16.0%)
Dec 2020
$99.15M(+272.5%)
$53.48M(+72.7%)
$99.15M(+88.4%)
Sep 2020
-
$30.97M(+143.1%)
$52.63M(+43.9%)
Jun 2020
-
$12.74M(+551.0%)
$36.57M(+11.2%)
Mar 2020
-
$1.96M(-71.9%)
$32.89M(+23.6%)
DateAnnualQuarterlyTTM
Dec 2019
$26.62M(+1527.3%)
$6.96M(-53.3%)
$26.62M(-27.0%)
Sep 2019
-
$14.91M(+64.4%)
$36.47M(+34.1%)
Jun 2019
-
$9.07M(+310.1%)
$27.20M(+155.6%)
Mar 2019
-
-$4.32M(-125.7%)
$10.64M(+670.7%)
Dec 2018
-$1.86M(+94.4%)
$16.81M(+198.2%)
-$1.86M(+91.4%)
Sep 2018
-
$5.64M(+175.2%)
-$21.58M(+12.5%)
Jun 2018
-
-$7.49M(+55.5%)
-$24.67M(-7.0%)
Mar 2018
-
-$16.82M(-480.5%)
-$23.05M(+30.4%)
Dec 2017
-$33.13M(+69.2%)
-$2.90M(-213.7%)
-$33.13M(+24.6%)
Sep 2017
-
$2.55M(+143.4%)
-$43.96M(+45.1%)
Jun 2017
-
-$5.88M(+78.2%)
-$80.00M(+22.7%)
Mar 2017
-
-$26.91M(-96.1%)
-$103.52M(+3.8%)
Dec 2016
-$107.59M(-7.7%)
-$13.72M(+59.0%)
-$107.59M(+10.3%)
Sep 2016
-
-$33.50M(-14.0%)
-$119.99M(-10.5%)
Jun 2016
-
-$29.39M(+5.1%)
-$108.60M(-6.1%)
Mar 2016
-
-$30.98M(-18.6%)
-$102.39M(-2.5%)
Dec 2015
-$99.88M(-34.5%)
-$26.12M(-18.2%)
-$99.88M(-35.4%)
Sep 2015
-
-$22.11M(+4.7%)
-$73.76M(-42.8%)
Jun 2015
-
-$23.19M(+18.5%)
-$51.66M(-9.6%)
Mar 2015
-
-$28.47M(-52.6%)
-$47.12M(-22.0%)
Dec 2014
-$74.24M(-40.8%)
-
-
Jun 2014
-
-$18.65M(+6.6%)
-$38.63M(-93.4%)
Mar 2014
-
-$19.98M
-$19.98M
Dec 2013
-$52.72M
-
-

FAQ

  • What is NovoCure Limited annual cash from operations?
  • What is the all-time high annual cash from operations for NovoCure Limited?
  • What is NovoCure Limited annual cash from operations year-on-year change?
  • What is NovoCure Limited quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for NovoCure Limited?
  • What is NovoCure Limited quarterly cash from operations year-on-year change?
  • What is NovoCure Limited TTM cash from operations?
  • What is the all-time high TTM cash from operations for NovoCure Limited?
  • What is NovoCure Limited TTM cash from operations year-on-year change?

What is NovoCure Limited annual cash from operations?

The current annual cash from operations of NVCR is -$26.37M

What is the all-time high annual cash from operations for NovoCure Limited?

NovoCure Limited all-time high annual cash from operations is $99.15M

What is NovoCure Limited annual cash from operations year-on-year change?

Over the past year, NVCR annual cash from operations has changed by +$46.97M (+64.04%)

What is NovoCure Limited quarterly cash from operations?

The current quarterly cash from operations of NVCR is $20.57M

What is the all-time high quarterly cash from operations for NovoCure Limited?

NovoCure Limited all-time high quarterly cash from operations is $53.48M

What is NovoCure Limited quarterly cash from operations year-on-year change?

Over the past year, NVCR quarterly cash from operations has changed by +$10.20M (+98.28%)

What is NovoCure Limited TTM cash from operations?

The current TTM cash from operations of NVCR is -$34.48M

What is the all-time high TTM cash from operations for NovoCure Limited?

NovoCure Limited all-time high TTM cash from operations is $128.40M

What is NovoCure Limited TTM cash from operations year-on-year change?

Over the past year, NVCR TTM cash from operations has changed by +$3.00M (+8.00%)
On this page